邱鹏, 倪晓娜. 基于NLRP3/caspase-1通路研究丹参提取物对系膜增生性肾小球肾炎大鼠的保护作用[J]. 临床肾脏病杂志, 2020, 20(1): 62-68. DOI: 10.3969/j.issn.1671-2390.2020.01.012
    引用本文: 邱鹏, 倪晓娜. 基于NLRP3/caspase-1通路研究丹参提取物对系膜增生性肾小球肾炎大鼠的保护作用[J]. 临床肾脏病杂志, 2020, 20(1): 62-68. DOI: 10.3969/j.issn.1671-2390.2020.01.012
    QIU Peng, NI Xiao-na. Study on protective effect of Salvia miltiorrhiza extract on mesangial proliferative glomerulonephritis in rats based on the NLRP3/caspase 1 pathway[J]. Journal of Clinical Nephrology, 2020, 20(1): 62-68. DOI: 10.3969/j.issn.1671-2390.2020.01.012
    Citation: QIU Peng, NI Xiao-na. Study on protective effect of Salvia miltiorrhiza extract on mesangial proliferative glomerulonephritis in rats based on the NLRP3/caspase 1 pathway[J]. Journal of Clinical Nephrology, 2020, 20(1): 62-68. DOI: 10.3969/j.issn.1671-2390.2020.01.012

    基于NLRP3/caspase-1通路研究丹参提取物对系膜增生性肾小球肾炎大鼠的保护作用

    Study on protective effect of Salvia miltiorrhiza extract on mesangial proliferative glomerulonephritis in rats based on the NLRP3/caspase 1 pathway

    • 摘要: 目的 基于NLRP3/caspase-1通路探讨丹参提取物对系膜增生性肾小球肾炎(mesangial proliferative glomerulonephritis,MsPGN)大鼠的保护作用。方法 取48只大鼠建立MsPGN模型,随机分为4组:(1)模型组:不给予药物治疗;(2)丹参提取物组:每日给予丹参提取物(10 mL/kg)灌胃;(3)VX-765组:每日给予VX-765(NLRP3炎性小体抑制剂,50 mg/kg)腹腔注射;(4)丹参提取物+VX-765组:每日给予丹参提取物(10 mL/kg)灌胃,并给予VX-765(50 mg/kg)腹腔注射。另取12只大鼠设为假手术组。各组均持续给药28 d。末次给药结束24 h后,收集各组大鼠24 h尿液,检测24 h尿蛋白含量;检测各组大鼠血清中BUN、Scr、IL-1β、IL-18水平;观察各组大鼠肾组织病理变化,并根据肾小球系膜细胞增殖程度、肾小管-间质病变程度进行病理评分;采用实时荧光定量PCR及免疫印迹法检测各组大鼠肾组织中NLRP3、caspase-1的mRNA和蛋白表达。结果 与假手术组相比,模型组大鼠出现肾小球体积变大、内部细胞数量增多,系膜细胞弥漫性增生、细胞基质增多,肾间质有炎性细胞浸润等肾组织病理损伤症状,肾小球系膜细胞增殖程度评分、肾小管-间质病理评分、24 h尿蛋白含量、血清BUN、Scr、IL-1β、IL-18、肾组织NLRP3及caspase-1表达显著升高(P<0.05);与模型组比较,丹参提取物组、VX-765组、丹参提取物+VX-765组大鼠上述病理损伤症状减轻,肾小球系膜细胞增殖程度评分、肾小管-间质病理评分、24 h尿蛋白含量、血清BUN、Scr、IL-1β、IL-18、肾组织NLRP3及caspase-1表达均显著降低(P<0.05);与丹参提取物组及VX-765组分别比较,丹参提取物+VX-765组大鼠上述病理损伤症状进一步减轻,肾小球系膜细胞增殖程度评分、肾小管-间质病理评分、24 h尿蛋白含量、血清BUN、Scr、IL-1β、IL-18、肾组织NLRP3及caspase-1表达均显著降低(P<0.05)。结论 丹参提取物可以减轻MsPGN大鼠炎症反应及系膜增生性病变,保护大鼠肾组织,修复大鼠肾功能,可能通过下调NLRP3/caspase-1通路实现。

       

      Abstract: Objective To investigate the protective effect of Salvia miltiorrhiza extract on mesangial proliferative glomerulonephritis (MsPGN) rats based on the NLRP3/caspase 1 pathway. Methods A total of 48 rats were selected to establish MsPGN models and randomly divided into 4 groups:(1)model group, not administered with any drug; (2)Salvia miltiorrhiza extract group, administered gastrically with Salvia miltiorrhiza extract (10 mL/kg) every day; (3)VX-765 group, administered with VX-765 (NLRP3 inflammatory body inhibitor, dosage:50 mg/kg)every day, by intraperitoneal injection; (4)Salvia miltiorrhiza extract + VX-765 group, administered gastrically with Salvia miltiorrhiza extract (10 mL/kg) every day, and with VX-765(50 mg/kg)by intraperitoneal injection. Another 12 rats were used as the sham operation group. The treatment time for each group was 28 days. At 24 hours after the last administration, 24-hour urine of rats in each group was collected to detect the 24 h-urinary protein content. The levels of BUN, Scr, IL-1β and IL-18 were detected in serum of rats in each group. Hematoxylin-eosin (HE) staining was used to detect the pathological changes of kidney tissues of rats in each group. Pathological scores were made according to the degree of proliferation of mesangial cells and tubulointerstitial lesions, and the expressions of NLRP3 and caspase-1 in kidney tissues of rats in each group were detected by real-time fluorescence quantitative PCR and immunoblotting. Results Compared with the sham operation group, in the model group, some renal pathological damage symptoms, including increased glomerular volume, increased number of internal cells, diffused mesangial cell proliferation, increased cell matrix, renal interstitial inflammatory cell infiltration, occurred; glomerular mesangial cell proliferation score, tubulointerstitial pathological score, urinary protein content, serum BUN, Scr, IL-1β and IL-18 levels, NLRP3 and caspase-1 expressions increased significantly (P<0.05). Compared with the model group, in the Salvia miltiorrhiza extract group, VX-765 group and Salvia miltiorrhiza extract +VX-765 group, the above pathological damage symptoms were alleviated; glomerular mesangial cell proliferation score, tubulointerstitial pathological score, the urinary protein content, serum BUN, Scr, IL-1β and IL-18 levels, NLRP3 and caspase-1 expressions were all decreased (P<0.05). Compared with the Salvia miltiorrhiza extract group and VX-765 group, in the Salvia miltiorrhiza extract + VX-765 group, the above pathological damage symptoms were further alleviated; and glomerular mesangial cell proliferation score, tubulointerstitial pathological score, the urinary protein content, serum BUN, Scr, IL-1β and IL-18 levels, NLRP3 and caspase-1 expressions were all decreased in Salvia miltiorrhiza extract + VX-765 group(P<0.05). Conclusions Salvia miltiorrhiza extract can alleviate the Inflammatory reaction and mesangial proliferative lesions of rats, protect rat kidney tissues and repair rat kidney function, possibly achieved by down-regulating the NLRP3/caspase 1 pathway.

       

    /

    返回文章
    返回